5-[3-(cyclopentylamino)-1-cyclopropyl-5-fluoro-7-hydroxy-2-oxoquinolin-6-yl]-1,1-dioxo-1,2,5-thiadiazolidin-3-one
C19H21FN4O5S — CID 165122506
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[3-(cyclopentylamino)-1-cyclopropyl-5-fluoro-7-hydroxy-2-oxoquinolin-6-yl]-1,1-dioxo-1,2,5-thiadiazolidin-3-one
5-[3-(cyclopentylamino)-1-cyclopropyl-5-fluoro-7-hydroxy-2-oxoquinolin-6-yl]-1,1-dioxo-1,2,5-thiadiazolidin-3-one (PubChem CID 165122506) has the molecular formula C19H21FN4O5S and a molecular weight of 436.47 g/mol. Its IUPAC name is 5-[3-(cyclopentylamino)-1-cyclopropyl-5-fluoro-7-hydroxy-2-oxoquinolin-6-yl]-1,1-dioxo-1,2,5-thiadiazolidin-3-one.
Molecular Properties
| Compound Name | 5-[3-(cyclopentylamino)-1-cyclopropyl-5-fluoro-7-hydroxy-2-oxoquinolin-6-yl]-1,1-dioxo-1,2,5-thiadiazolidin-3-one |
|---|---|
| PubChem CID | 165122506 |
| Molecular Formula | C19H21FN4O5S |
| Molecular Weight | 436.47 g/mol |
| Exact Mass | 436.12 |
| IUPAC Name | 5-[3-(cyclopentylamino)-1-cyclopropyl-5-fluoro-7-hydroxy-2-oxoquinolin-6-yl]-1,1-dioxo-1,2,5-thiadiazolidin-3-one |
| SMILES | O=C1CN(c2c(O)cc3c(cc(NC4CCCC4)c(=O)n3C3CC3)c2F)S(=O)(=O)N1 |
| InChI | InChI=1S/C19H21FN4O5S/c20-17-12-7-13(21-10-3-1-2-4-10)19(27)24(11-5-6-11)14(12)8-15(25)18(17)23-9-16(26)22-30(23,28)29/h7-8,10-11,21,25H,1-6,9H2,(H,22,26) |
| InChIKey | HTIMEAFXSXQUCL-UHFFFAOYSA-N |
| XLogP | 1.72 |
| TPSA | 120.74 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 436.47 |
| LogP ≤ 5 | 1.72 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 165122506 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.